Publications | Lund University Publications

1 – 10 of 21

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Olsson-Str%C3%B6mberg%2C+Ulla%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Olsson-Str%C3%B6mberg%2C+Ulla%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2022
Mark Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per ; Flygt, Hjalmar ; Richter, Johan ^LU ; Olsson-Strömberg, Ulla ; Wadenvik, Hans ; Dreimane, Arta ; Myhr-Eriksson, Kristina and Zhao, Jingcheng , et al. (2022) In American Journal of Hematology 97(4). p.421-430
- Contribution to journal › Article
2021
Mark Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten ; Dremaine, Arta ; Lübking, Anna ^LU ; Markevärn, Berit ; Myhr-Eriksson, Kristina ; Olsson, Karin ; Olsson-Strömberg, Ulla and Själander, Anders , et al. (2021) In British Journal of Haematology 193(5). p.915-921
- Contribution to journal › Article
Mark Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP : Five-year follow-up of the NordCML007 study
Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper ; Richter, Johan ^LU ; Koskenvesa, Perttu ; Mustjoki, Satu ; Majeed, Waleed ; Lübking, Anna ^LU ; Dreimane, Arta and Markevärn, Berit , et al. (2021) In European Journal of Haematology 107(6). p.617-623
- Contribution to journal › Article
2020
Mark Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy
Söderlund, Stina ; Persson, Inger ; Ilander, Mette ; Guilhot, Joëlle ; Hjorth-Hansen, Henrik ; Koskenvesa, Perttu ; Richter, Johan ^LU ; Saussele, Susanne ; Mustjoki, Satu and Olsson-Strömberg, Ulla (2020) In Leukemia Research 90.
- Contribution to journal › Article
2019
Mark Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Kreutzman, Anna ; Yadav, Bhagwan ; Brummendorf, Tim H. ; Gjertsen, Bjorn Tore ; Lee Hee, Moon ; Janssen, Jeroen ; Kasanen, Tiina ; Koskenvesa, Perttu ; Lofti, Kourosh and Markevärn, Berit , et al. (2019) In OncoImmunology 8(9).
- Contribution to journal › Article
2018
Mark Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI) : a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Saussele, Susanne ; Richter, Johan ^LU ; Guilhot, Joelle ; Gruber, Franz X. ; Hjorth-Hansen, Henrik ; Almeida, Antonio ; Janssen, Jeroen J.W.M. ; Mayer, Jiri ; Koskenvesa, Perttu and Panayiotidis, Panayiotis , et al. (2018) In The Lancet Oncology 19(6). p.747-757
- Contribution to journal › Article
2017
Mark No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia : A population-based study in Sweden
Gunnarsson, Niklas ; Höglund, M. ; Stenke, L ; Sandin, F. ; Björkholm, M ; Dreimane, Arta ; Lambe, M. ; Markevärn, Berit ; Olsson-Strömberg, Ulla and Wadenvik, Hans , et al. (2017) In Leukemia 31(8). p.1825-1827
- Contribution to journal › Letter
Mark Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
Söderlund, Stina ; Dahlén, Torsten ; Sandin, Fredrik ; Olsson-Strömberg, Ulla ; Creignou, Maria ; Dreimane, Arta ; Lübking, Anna ^LU ; Markevärn, Berit ; Själander, Anders and Wadenvik, Hans , et al. (2017) In European Journal of Haematology 98(1). p.57-66
- Contribution to journal › Article
Mark Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
Warfvinge, Rebecca ^LU ; Geironson Ulfsson, Linda ^LU ; Sommarin, Mikael N E ^LU ; Lang, Stefan ^LU ; Karlsson, Christine ^LU ; Roschupkina, Teona ^LU ; Stenke, Leif ; Stentoft, Jesper ; Olsson-Strömberg, Ulla and Hjorth-Hansen, Henrik , et al. (2017) In Blood 129(17). p.2384-2394
- Contribution to journal › Article
Mark Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
Rajala, Hanna L M ; El Missiry, Mohamed ; Ruusila, Anniina ; Koskenvesa, Perttu ; Brümmendorf, Tim H. ; Gjertsen, Bjorn T. ; Janssen, Jeroen Jwm ; Lotfi, Kourosh ; Markevärn, Berit and Olsson-Strömberg, Ulla , et al. (2017) In Journal of Cancer Research and Clinical Oncology 143(8). p.1543-1554
- Contribution to journal › Article

« previous
1
2
3
next »

your query:: Remove author: Olsson-Strömberg, Ulla